Frontiers in Molecular Biosciences · 2021 · 22 citations · 35 references
PharmacyChemical BiologyMolecular BiologyDrug DesignDrug DiscoveryStructural BiologyComputational Drug DiscoveryIntrinsically Disordered ProteinsDisorderDisorder In Signaling ProteinsFuzzy Protein InteractionsIntrinsic Disorder AnalysisIntrinsic Disorder PredictionIntrinsic Disorder PropensityStructure-based Screening
Transcription factors (TFs) are one of the most promising but underutilized classes of drug targets. The high degree of intrinsic disorder in both the structure and the interactions (i.e., "fuzziness") of TFs is one of the most important challenges to be addressed in this context. Here, we discuss the impacts of fuzziness on transcription factor drug discovery, describing how disorder poses fundamental problems to the typical drug design, and screening approaches used for other classes of proteins such as receptors or enzymes. We then speculate on ways modern biophysical and chemical biology approaches could synergize to overcome many of these challenges by directly addressing the challenges imposed by TF disorder and fuzziness.
35
The promise and peril of chemical probes
C.H. Arrowsmith, James E. Audia, Christopher P. Austin et al. · Nature Chemical Biology · 2015 · 850 citations · Full text
Intrinsic Disorder in Transcription Factors
Jiangang Liu, Narayanan B. Perumal, Christopher J. Oldfield et al. · Biochemistry · 2006 · 821 citations · Full text
Acid blobs and negative noodles
Paul B. Sigler · Nature · 1988 · 450 citations · Full text
Low molecular weight inhibitors of Myc–Max interaction and function
Xiaoying Yin, Christine Giap, John S. Lazo et al. · Oncogene · 2003 · 430 citations